Navigation Links
BioMS Medical Announces 2009 Year End Results
Date:3/16/2010

sks detailed from time to time in the Corporation's ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that dirucotide will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

    BioMS Medical Corp.
    Consolidated Balance Sheet
    December 31, 2009 and 2008
    -------------------------------------------------------------------------

    (expressed in thousands of Canadian dollars)

                                                          2009          2008
                                                             $             $
    Assets

    Current assets
    Cash and cash equivalents                           48,774        87,826
    Short-term investments                               2,662         2,614
    Goods and services tax recoverable                     351           299
    Prepaid clinical trial costs                             -         2,227
    Recoverable from collaboration partner                 424           267
    Other prepaid expenses                                 112            54
                                                   --------------------------

                                                        52,323        93,287

    Prepaid clinical trial costs                             -           790

    Licensing costs                                          -         5,910

    Property and equipment                                 350           517
                                                   --------------------------

                                                     
'/>"/>
SOURCE  BioMS Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 

Related biology technology :

1. BioMS Medical reports Spectral receives FDA approval to initiate pivotal trial and closes financing for $19.5 million
2. Spectral diagnostics Raises $14 million and enters into strategic collaboration with BioMS Medical to commercialize treatment for sepsis
3. BioMS Medical provides corporate update
4. BioMS Medical Announces Third Quarter 2009 Results
5. BioMS Medical announces second quarter 2009 results
6. BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences
7. BioMS Medical to participate in panel session at Bio International Convention 2009
8. BioMS Medical Announces First quarter 2009 results
9. BioMS Medical to present at Alberta Economic Forum in Geneva
10. BioMS Medical to present at BioFinance 2009
11. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... CARLSBAD, Calif. , June 19, 2013 /PRNewswire/ ... soil, plant, stool and other challenging microbial nucleic ... Soil Protein Extraction Kit, for extraction of pure ... the protein world coincides with the 20 th ... ever growing innovation capabilities. (Photo: ...
(Date:6/19/2013)... Bayer CropScience will honor Illinois beekeeper Steve McNair ... Award. The award will be announced at Bayer’s ... an event where supporters of pollinator health celebrate the ... , The Bayer Bee Care Community Leadership Award recognizes ... bee colony to benefit their community. Applicants are judged ...
(Date:6/19/2013)... MUMBAI, India , June ... Bharat Book Bureau presents ... Product and Formulation Technology Licensing ... ( http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/innovative-drug-delivery-systems-novel-product-and-formulation-technology-licensing-opportunities-for-generic-pharmaceutical-companies.html ) ... sustained or controlled release drugs ...
(Date:6/19/2013)... 2013 Applied Rigaku Technologies, Inc. is ... the measurement of sulfur in ultra-low sulfur diesel (ULSD) ... benchtop EDXRF analyzer . The analysis detailed in Rigaku ... 13032. This International Standard specifies an energy dispersive ... sulfur content in automotive gasoline. , Regulations around the ...
Breaking Biology Technology:MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 2Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 3Community Mentor Wins Inaugural Bayer CropScience Bee Care Leadership Award 4Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Rigaku Publishes New Application Note for Analysis of ULSD Per ISO 13032 2
... researchers have created a nanoscale light sensor that can ... optic and electronic devices with new functionality. The team, ... at Madison, reports in Nature Photonics that ... The group, led by Jeremy Levy, a professor ...
... the 2010 ICO Prize for pioneering contributions to attosecond ... scientific discipline is to capture snapshots of the inner ... important insights into the actual course of chemical reactions, ... interactions between light and matter. "An attosecond is ...
... ... ... var shortURL = ""; BitlyCB.alertResponse = function(data) ... first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var key in first_result) { ...
Cached Biology Technology:Pitt-led team develops nanoscale light sensor compatible with 'Etch-a-Sketch' nanoelectronic platform 22010 ICO Prize is awarded to TUM physicist Reinhard Kienberger 2MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 2MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 3MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 4MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 5MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 6MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 7MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 8MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 9
(Date:6/19/2013)... and birds are threatened with extinction as a result of ... from The Ohio State University in the US. Their work ... of the human population will continue to pose a threat ... to be a threshold above which population growth would cease ... online in Springer,s journal, Human Ecology . , It ...
(Date:6/19/2013)... 2013 A decade-long JDRF-funded study led by ... Mnchen, Germany, is providing a deeper understanding of ... developing type 1 diabetes (T1D), highlighting the importance ... disease. The study, "Seroconversion to Multiple Islet Autoantibodies ... was published today in The Journal of ...
(Date:6/19/2013)... University study offers further proof that the divergence of ... years ago was profoundly influenced by mutations to DNA ... off. , The study, published June 9 in ... that regulation of genes must play an important role ... and chimps in the proteins produced by genes. Indeed, ...
Breaking Biology News(10 mins):Are we pushing animals over the edge? 2New data on islet autoantibodies in young children defines early type 1 diabetes development 2New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3
... rocks scattered across the upper Midwest and elsewhere throughout ... clues to the environment of the early Earth more ... formations or BIFs, these ancient rocks formed between 3.8 ... the bottom of the ocean. The stripes represent alternating ...
... Panama Canal in a Boston Whaler may sound like the ... story brandishes a butterfly net and studies the effects of ... Institute. , "Our long-term study shows that El ... Robert Srygley, former Smithsonian post doctoral fellow who is now ...
... the structure of an unusual enzyme which can be used ... discovery, by scientists in the York Structural Biology Laboratory and ... of plants that can help tackle pollution caused by royal ... have identified bacteria that use RDX as a food source ...
Cached Biology News:Banded rocks reveal early Earth conditions, changes 2Banded rocks reveal early Earth conditions, changes 3Panama butterfly migrations linked to El Nio, climate change 2
Rabbit polyclonal to Phosphothreonine-Proline / Phosphoserine-Proline ( Abpromise for all tested applications)....
Mouse monoclonal [7C6] to Bcr-abl ( Abpromise for all tested applications). SwissProtID: P11274...
Chicken polyclonal to Thioredoxin domain containing 9 ( Abpromise for all tested applications). Antigen: Full length protein (Human) Entrez Gene ID: 10190 Swiss Protein ID: O14530...
Mouse anti-IkBa/MAD-3 Class: Antibody Product Group: Signalling molecules and phospho-specific Antibody...
Biology Products: